INTRODUCTION
============

*Salmonella* and *Shigella* spp. are the most frequently found and deadly enteric bacterial pathogens. For instance, each year 500,000 cases of diarrheal shigellosis and about 1.2 million cases of nontyphoidal salmonellosis with 380 deaths are recorded in the United States \[[@B1][@B2][@B3]--[@B4]\]. Moreover, in developing countries *Salmonella* infections are responsible for 1 million deaths annually and these mortality rates are likely to increase due to the emergence of resistance to commonly implemented antibiotics \[[@B5], [@B6]\]. In this overall scenario, new alternative and cost-effective therapeutic approaches are needed.

Bacteriophages are highly species-specific self-propagating viruses that can infect and lyse bacteria. Their employment is part of the standard medical practice in countries of the former Soviet Union, whereas in Western nations the use of phage therapy is unfamiliar, and this has led to a lack of studies analyzing efficacy and possible alternatives to antibiotics \[[@B7], [@B8]\].

Numerous *in vitro* and *in vivo* reports exploring both lytic activity and clinical effectiveness to control *Salmonella* infections are available. However, such analyses have exclusively used monophages and focused on reducing contamination of food stuffs or intestinal colonization in food animals \[[@B9][@B10][@B11][@B12]--[@B13]\]. With regard to *Shigella*, Mai *et al* tested a phage cocktail (ShigActive^TM^) in a mice model obtaining encouraging results \[[@B14]\].

To our knowledge, data regarding the *in vitro* activity of bacteriophage cocktails against large collections of *Salmonella* and *Shigella* spp. strains are still lacking. In this study, for the first time, we explored the *in vitro* activity of 3 commercially available bacteriophage cocktails currently implemented in the country of Georgia to treat human intestinal infections.

METHODS
=======

The following cocktails of sterile-filtrate phage lysates of different bacterial species were tested: *PYO Bacteriophage, INTESTI Bacteriophage* (Eliava Biopreparations, Tbilisi, Georgia; concentration of 10^5-6^ Plaque Forming Units, PFU/mL), and *Septaphage* (Biochimpharm, Tbilisi, Georgia; 10^5^ PFU/mL). *PYO* targets *Escherichia coli, Proteus* spp., *Pseudomonas aeruginosa, Staphylococcus* spp., and *Streptococcus* spp., whereas *INTESTI* and *Septaphage* target over 12 gastrointestinal pathogens, such as *Shigella, Salmonella, Proteus, Staphylococcus, Pseudomonas* spp. and different serovars of enteropathogenic *E. coli. PYO* is used to treat purulent skin and surgical, oral, enteral, and gynecological infections, whereas *INTESTI* and *Septaphage* are implemented for intestinal infections \[[@B15]\]. Notably, *INTESTI* is the only molecularly well-characterized phage cocktail \[[@B16]\].

The collection of strains tested during the present study included contemporary *Salmonella* (n = 30) and *Shigella* spp. (n = 20) isolated from human infections which occurred in Switzerland. Species identification (ID) was routinely obtained using the matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS; Bruker). The ID confirmation and further typing were performed at the National Reference Laboratory for Enteropathogenic Bacteria and Listeria (Institute for Food Safety and Hygiene, Zurich, Switzerland). The antibiotic susceptibility profiles were obtained by disc-diffusion tests \[[@B17]\]. Most *Salmonella* spp. strains were pan-susceptible to tested antibiotics (ampicillin, ceftriaxone, cotrimoxazole, chloramphenicol, nalidixic acid, and ciprofloxacin), whereas only ceftriaxone was always active *in vitro* against isolates of *Shigella* spp. ([Supplementary Table 1](#TS1){ref-type="table"}).

Phage susceptibility was determined with the spot test with double agar overlay method \[[@B18]\]. Briefly, 100 μl of a 0.5 McFarland bacterial suspension was mixed in a brain heart infusion (BHI) agarose matrix (0.6%), which was then distributed to solidify on a standard BHI agar plate. Then, 10 μl of each phage-suspension was spotted on the plate and incubated overnight. The day after, lysis zones were quantified \[[@B18]\]. Specifically, strains showing confluent lysis (complete clearing: ++++), semi-confluent lysis (clearing throughout, but with faint hazy background: +++), opaque lysis (turbidity throughout the cleared zone: ++), and *taches vierges* (individual clear or opaque plaques: +) were defined as susceptible to the phage compounds tested. Strains showing no activity (no clearing: *R*) were defined as resistant. For all strains (n = 50) susceptibility tests were performed in duplicate and on distinct days.

RESULTS AND DISCUSSION
======================

As shown in [Table 1](#T1){ref-type="table"}, the overall susceptibility of *Salmonella* spp. to *INTESTI* and *Septaphage* was 86.7% (of which 23/30 were +++ or ++++) and 76.7% (none of which were +++ or ++++), respectively (examples in [Supplementary Figure 1](#FS1){ref-type="fig"}). With regard to *Shigella* spp., the overall susceptibility to *INTESTI* and *Septaphage* was 95% (of which 9/20 were +++ or ++++) and 55% (of which 3/20 were +++ or ++++), respectively. This data is promising, but we should note that the spot test can lead to an overestimation of the susceptibility as a consequence of the *lysis-from-without* phenomenon \[[@B19]\].

###### 

Summary of the susceptibility of the *Salmonella* and *Shigella* spp. strains to the 3 commercial bacteriophage cocktails

  Phage Cocktails                    Strain groups                Results of the spot test (%) ^[a](#TF1-1){ref-type="table-fn"}^                        
  ---------------------------------- ---------------------------- ----------------------------------------------------------------- ------ ------ ------ ------
  *PYO Bacteriophage* (Eliava)       Overall strains (n = 50)     56.0                                                              4.0    24.0   12.0   4.0
                                     *Salmonella* spp. (n = 30)   90.0                                                              3.3    0.0    3.3    3.3
                                     *Shigella* spp. (n = 20)     5.0                                                               5.0    55.0   30.0   5.0
  *INTESTI Bacteriophage* (Eliava)   Overall strains (n = 50)     10.0                                                              6.0    20.0   36.0   28.0
                                     *Salmonella* spp. (n = 30)   13.3                                                              3.3    6.7    33.3   43.3
                                     *Shigella* spp. (n = 20)     5.0                                                               10.0   40.0   40.0   5.0
  *Septaphage* (Biochimpharm)        Overall strains (n = 50)     32.0                                                              42.0   20.0   0.0    6.0
                                     *Salmonella* spp. (n = 30)   23.3                                                              53.3   23.3   0.0    0.0
                                     *Shigella* spp. (n = 20)     45.0                                                              25.0   15.0   0.0    15.0

^a^ Strains were defined as susceptible to the bacteriophages when confluent lysis (ie, complete clearing: ++++), semi-confluent lysis (ie, clearing throughout but with faint hazy background: +++), opaque lysis (ie, turbidity throughout the cleared zone: ++), *taches vierges* (ie, a few individual plaques: +) were recorded. Strains showing no activity (ie, no clearing "R") were defined as resistant.

We did not expect any activity for *PYO* against our strains because, according to the manufacturer, this preparation should not contain lytic phages against *Salmonella* spp. and *Shigella* spp. However, we were surprised to note that this cocktail was active against 10% (of which 2/30 were +++ or ++++) of *Salmonella* spp. and, more importantly, against 95% (of which 7/20 were +++ or ++++) of *Shigella* spp. This could be explained by the presence of bacteriophages unable to selectively differentiate *Salmonella* and *Shigella* spp. from *E. coli* (all 3 being phylogenetically closely related bacterial species, especially the latter 2 \[[@B20]\]) that might share several common phage targets \[[@B21]\]. Moreover, taking into account the *lysis-from-without* phenomenon where a high multiplicity of infection can lead to bacterial death without infection, we are aware that by exclusively using the spot test, our susceptibility results might be slightly overestimated \[[@B19]\].

In conclusion, we showed the distinct spectrum and lytic activity of commercial bacteriophage cocktails targeting *Salmonella* and *Shigella* species. In particular, *Septaphage* proved to be active, though overall weakly, against 68% of the tested strains, whereas *INTESTI* exhibited a strong response against 90% of our isolates. Therefore, our results seem promising, especially for the latter biopreparation against *Salmonella enterica* infections. Nevertheless, such speculation should be supported by further animal studies together with human clinical trials in order to confirm efficacy and safety of cocktails. We also emphasize the importance of large *in vitro* screening analyses aimed to assess the activity of such biopreparations against contemporary multidrug-resistant strains emerging worldwide \[[@B2], [@B22], [@B23]\]. The sum of these steps, if successful, could lead to the maturation---also in Western countries---of an alternative approach for the treatment of bacillary dysenteries and salmonellosis.
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###### 

Characteristics of the 30 *Salmonella* and 20 *Shigella* spp. strains and susceptibility to 3 commercial bacteriophage cocktails

  No.   ID strain   Species                                 Source          Detection Month/Year   Susceptibility according to CLSI   Bacteriophage Susceptibility ^[a](#TFS1-1){ref-type="table-fn"}^                                     
  ----- ----------- --------------------------------------- --------------- ---------------------- ---------------------------------- ------------------------------------------------------------------ ---- ---- ---- ---- ------ ------ ------
  1     6301.21     *S. enteritidis*                        Stool           08/16                  S                                  S                                                                  S    S    S    S    ++++   \+     R
  2     6301.22     *S. enteritidis*                        Stool           08/16                  S                                  S                                                                  S    S    S    S    R      \+     R
  3     6301.23     *S. enterica subsp. enterica 4,12:i*    Stool           08/16                  S                                  S                                                                  S    S    S    S    R      \+     R
  4     6212.52     *S. enteritidis*                        Stool           08/16                  S                                  S                                                                  S    S    S    S    R      \+     R
  5     6212.46     *S. enterica subsp. enterica 4,12:i*    Stool           08/16                  R                                  S                                                                  S    S    S    S    R      \+     R
  6     6212.47     *S. enteritidis*                        Stool           08/16                  S                                  S                                                                  S    S    S    S    +++    \+     R
  7     6211.59     *S. enterica subsp. enterica 6,7:y:-*   Stool           08/16                  S                                  S                                                                  S    S    S    S    ++++   ++     +++
  8     6211.25     *S. enteritidis*                        Stool           08/16                  S                                  S                                                                  S    S    S    S    +++    \+     R
  9     5804.66     *S. paratyphi A*                        Blood culture   04/15                  S                                  S                                                                  S    S    R    I    +++    \+     R
  10    6102.20     *S. typhimurium*                        Urine           01/16                  S                                  S                                                                  S    S    S    S    +++    R      R
  11    6103.32     *S. typhimurium*                        Stool           02/16                  S                                  S                                                                  S    S    S    S    ++++   \+     R
  12    6107.71     *S. typhimurium*                        Stool           03/16                  S                                  S                                                                  S    S    S    S    ++++   ++     R
  13    6007.27     *S. panama*                             Stool           11/15                  S                                  S                                                                  S    S    S    S    ++++   \+     R
  14    5804.47     *S. paratyphi B*                        Stool           04/15                  S                                  S                                                                  S    S    S    S    +++    \+     R
  15    5602.57     *S. typhimurium*                        Blood culture   09/14                  S                                  S                                                                  S    S    S    S    ++++   ++     R
  16    5905.07     *S. enteritidis*                        Stool           08/15                  S                                  S                                                                  S    S    S    S    +++    \+     R
  17    5905.08     *S. enteritidis*                        Stool           08/15                  S                                  S                                                                  S    S    S    S    ++++   ++     R
  18    5602.08     *S. enteritidis*                        Stool           09/14                  S                                  S                                                                  S    S    S    S    +++    ++     R
  19    5512.03     *S. enteritidis*                        Blood culture   08/14                  S                                  S                                                                  S    S    S    S    ++++   \+     R
  20    5603.72     *S. enteritidis*                        Blood culture   09/14                  S                                  S                                                                  S    S    S    S    +++    ++     R
  21    4608.23     *S. paratyphi A*                        Stool           12/10                  S                                  S                                                                  S    S    R    S    ++++   R      R
  22    4504.56     *S. paratyphi A*                        Blood culture   06/10                  S                                  S                                                                  S    S    R    I    ++++   R      R
  23    6104.03     *S. paratyphi B*                        Blood culture   02/16                  S                                  S                                                                  S    S    S    S    +++    R      R
  24    6201.74     *S. paratyphi B*                        Stool           05/16                  S                                  S                                                                  S    S    S    S    ++     \+     R
  25    5902.41     *S. typhimurium*                        Stool           07/15                  S                                  S                                                                  S    S    S    S    ++++   R      R
  26    5910.36     *S. typhimurium*                        Stool           09/15                  S                                  S                                                                  S    S    S    S    ++++   R      R
  27    4108.64     *S. oranienburg*                        Stool           03/09                  S                                  S                                                                  S    S    S    S    \+     R      R
  28    4310.33     *S. oranienburg*                        Stool           12/09                  S                                  S                                                                  S    S    S    S    +++    \+     \+
  29    1490.92     *S. choleraesuis*                       na              na                     \-                                 \-                                                                 \-   \-   \-   \-   ++++   ++     ++++
  30    6302.34     *S. enteritidis*                        Stool           9/16                   S                                  S                                                                  S    S    S    S    ++     \+     R
  31    6101.40     *S. sonnei*                             Stool           01/16                  S                                  S                                                                  R    S    S    S    +++    \+     +++
  32    6105.15     *S. sonnei*                             Stool           03/16                  S                                  S                                                                  R    S    S    S    +++    \+     +++
  33    6108.73     *S. sonnei*                             Stool           04/16                  \-                                 \-                                                                 \-   \-   \-   \-   +++    ++++   +++
  34    6110.62     *S. sonnei*                             Stool           04/16                  R                                  S                                                                  R    S    S    S    ++     \+     +++
  35    6003.54     *S. flexneri*                           Stool           10/15                  \-                                 \-                                                                 \-   \-   \-   \-   ++++   R      +++
  36    6004.50     *S. flexneri*                           Stool           11/15                  S                                  S                                                                  R    S    R    S    ++     R      ++
  37    5906.08     *S. flexneri*                           Stool           08/15                  S                                  S                                                                  S    S    S    S    ++     R      ++
  38    5509.52     *S. flexneri*                           Stool           08/14                  R                                  S                                                                  R    R    S    S    R      R      R
  39    6306.26     *S. sonnei*                             Stool           10/16                  S                                  S                                                                  R    S    S    S    +++    ++++   ++
  40    5703.48     *S. sonnei*                             Stool           11/14                  S                                  S                                                                  R    S    R    R    \+     \+     \+
  41    5611.08     *S. sonnei*                             Stool           11/14                  \-                                 \-                                                                 \-   \-   \-   \-   +++    ++++   +++
  42    5605.11     *S. sonnei*                             Stool           10/14                  S                                  S                                                                  R    S    S    S    ++     ++     ++
  43    5402.22     *S. sonnei*                             Stool           03/14                  S                                  S                                                                  R    S    R    R    ++     ++     ++
  44    5312.31     *S. sonnei*                             Stool           02/14                  R                                  S                                                                  S    S    S    S    ++     ++     ++
  45    5203.63     *S. sonnei*                             Stool           05/13                  S                                  S                                                                  R    S    S    S    ++     \+     ++
  46    6209.65     *S. flexneri*                           Stool           08/16                  \-                                 \-                                                                 \-   \-   \-   \-   +++    R      ++
  47    4907.58     *S. flexneri*                           Stool           02/12                  S                                  S                                                                  R    R    R    R    +++    R      ++++
  48    4706.22     *S. flexneri*                           Stool           04/11                  S                                  S                                                                  R    S    R    S    \+     R      ++
  49    4611.14     *S. flexneri*                           Stool           01/11                  S                                  S                                                                  R    S    S    S    ++     R      ++
  50    4512.64     *S. flexneri*                           Stool           09/10                  R                                  S                                                                  S    R    S    S    +++    R      ++

**Note.** AMP, ampicillin; CRO, ceftriaxone; SXT, cotrimoxazole; CHL, chloramphenicol; NAL, nalidixic acid; CIP, ciprofloxacin; R, resistant; I, intermediate; S, susceptible; na, not available; -, not tested.

^a^ Strains were defined as susceptible to the bacteriophages when confluent lysis (ie, complete clearing: ++++), semi-confluent lysis (ie, clearing throughout but with faint hazy background: +++), opaque lysis (ie, turbidity throughout the cleared zone: ++), *taches vierges* (ie, a few individual plaques: +) were recorded. Strains showing no activity (ie, no clearing "R") were defined as resistant.

![Examples of bacteriophage susceptibility results (see [Supp. Table 1](#TS1){ref-type="table"}) for 2 *Salmonella* and 2 *Shigella* spp. strains. EI, Eliava *INTESTI Bacteriophage* cocktail; EP, Eliava *PYO Bacteriophage* (Eliava) cocktail; BS, Biochimpharm *Septaphage Bacteriophage* cocktail.](pai-3-072-s001){#FS1}
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